These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma. Robinson SM, Rahman A, Haugk B, French JJ, Manas DM, Jaques BC, Charnley RM, White SA. Eur J Surg Oncol; 2012 Apr; 38(4):333-9. PubMed ID: 22317758 [Abstract] [Full Text] [Related]
10. Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients. Parekh JR, Wang SC, Bergsland EK, Venook AP, Warren RS, Kim GE, Nakakura EK. Pancreas; 2012 Aug; 41(6):840-4. PubMed ID: 22781907 [Abstract] [Full Text] [Related]
11. Analysis of recurrence after resection of well-differentiated non-functioning pancreatic neuroendocrine tumors. Tan QQ, Wang X, Yang L, Chen YH, Tan CL, Zhu XM, Ke NW, Liu XB. Medicine (Baltimore); 2020 Jun 12; 99(24):e20324. PubMed ID: 32541455 [Abstract] [Full Text] [Related]
18. The prognostic analysis of lymph node-positive gastric cancer patients following curative resection. Deng J, Liang H, Sun D, Pan Y. J Surg Res; 2010 Jun 01; 161(1):47-53. PubMed ID: 19783008 [Abstract] [Full Text] [Related]